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Ethnic Differences in Body Fat Deposition and Liver Fat 
Content in Two UK-Based Cohorts
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Rajarshi Banerjee4, Hanieh Yaghootkar1,5,6, Jimmy D. Bell1, and E. Louise Thomas 1
Objective: Differences in the content and distribution of body fat and ec-
topic lipids may be responsible for ethnic variations in metabolic disease 
susceptibility. The aim of this study was to examine the ethnic distribution 
of body fat in two separate UK-based populations.
Methods: Anthropometry and body composition were assessed in two 
separate UK cohorts: the Hammersmith cohort and the UK Biobank, 
both comprising individuals of South Asian descent (SA), individuals of 
Afro-Caribbean descent (AC), and individuals of European descent (EUR). 
Regional adipose tissue stores and liver fat were measured by magnetic 
resonance techniques.
Results: The Hammersmith cohort (n = 747) had a mean (SD) age of 
41.1 (14.5) years (EUR: 374 men, 240 women; SA: 68 men, 22 women; 
AC: 14 men, 29 women), and the UK Biobank (n = 9,533) had a mean 
(SD) age of 55.5 (7.5) years (EUR: 4,483 men, 4,873 women; SA: 80 men, 
43 women, AC: 31 men, 25 women). Following adjustment for age and 
BMI, no significant differences in visceral adipose tissue or liver fat were 
observed between SA and EUR individuals in the either cohort.
Conclusions: Our data, consistent across two independent UK-based 
cohorts, present a limited number of ethnic differences in the distribution 
of body fat depots associated with metabolic disease. These results sug-
gest that the ethnic variation in susceptibility to features of the metabolic 
syndrome may not arise from differences in body fat.
Obesity (2020) 0, 1-11. 
Introduction
Differences in anthropometry and body composition are associated with increased or de-
creased susceptibility of specific ethnicities to obesity-related metabolic disorders (1-3). 
Compared with white individuals of European descent (EUR), individuals of South Asian 
descent (SA) have higher waist circumference (WC), higher waist to hip ratio (4,5), and 
5% to 7% higher total body fat at any given BMI (6). Furthermore, elevated central adipos-
ity in SA has been linked to greater risk of developing type 2 diabetes (T2D), insulin resis-
tance, and cardiovascular disease at a lower BMI compared with EUR (7). Accumulation 
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Study Importance
What is already known?
►	Ethnic differences in susceptibility to 
metabolic disease are well established.
►	Compared with individuals of European 
descent (EUR), individuals of South 
Asian descent (SA) have a higher waist 
circumference and higher total body fat 
at any given BMI.
►	Elevated central adiposity in SA has 
been linked to greater risk of developing 
type 2 diabetes, insulin resistance, and 
cardiovascular disease at a lower BMI 
compared with EUR.
What does this study add?
►	We examined the ethnic distribu-
tion of body fat in EUR, SA, and indi-
viduals of Afro-Caribbean descent in 
two separate UK-based populations: 
the Hammersmith cohort and the UK 
Biobank.
►	Our results, consistent across both co-
horts, present a limited number of ethnic 
differences in the distribution of body 
fat depots associated with metabolic 
disease.
How might these results change the 
direction of research?
►	Conventional thinking suggests that 
differences in body fat distribution are 
responsible for the ethnic variation in 
metabolic disease susceptibility.
►	Our data indicate that alternative mech-
anisms should be investigated.
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of liver fat is also strongly linked to the development of insulin resis-
tance (8), with SA presenting higher levels both postnatally (9) and in 
adulthood (10).
Individuals of Afro-Caribbean descent (AC) exhibit higher muscle mass 
and less central adiposity compared with EUR yet have an increased 
risk of developing hypertension, stroke, and T2D (11,12). The greater 
susceptibility to develop metabolic diseases in AC therefore appears to 
be at odds with a favorable profile of reduced body fat and increased 
muscle mass. Accurate phenotyping including body fat content and dis-
tribution is therefore required to determine the potential contribution 
to ethnic differences in metabolic disease. Previous studies assessing 
the impact of ethnicity on body fat content have often relied on indirect 
measurements such as bioelectrical impedance, rather than direct imag-
ing methods for precise mapping and quantification of adiposity (13). 
As such, there are relatively limited available data regarding specific 
patterns of body fat distribution and liver fat content in different ethnic 
groups (14).
In this study, we used magnetic resonance (MR) techniques to assess 
body fat distribution and anthropometry in two separate UK-based 
populations, the Hammersmith cohort and the UK Biobank cohort, 
comprising adult EUR, SA, and AC of both sexes.
Methods
Study population 1: Hammersmith cohort
Subjects. Healthy adult (age ≥ 18 years) volunteers of both sexes 
were recruited from the UK general population in West London 
between 1995 and 2014 (15). All volunteers provided written consent, 
with study ethics obtained from the ethics committee of Hammersmith 
Hospital and Queen Charlotte’s and Chelsea Hospital London Research 
Ethics Committee (REC: 07Q04011/19). Volunteers were recruited 
via advertisement in websites, newspapers, and academic newsletters. 
Participants of all ethnicities were invited to take a part. Individuals 
suffering from claustrophobia, individuals who were pregnant, and 
those with metal implants (MR contraindication) were excluded.
Ethnicity classification. Ethnicity was self-reported. SA included 
participants from Indian, Pakistani, Bangladeshi, and other Asian 
backgrounds. AC included African, Caribbean, and other black 
backgrounds. EUR included British, Irish, and other white backgrounds.
Anthropometry measurements. Body mass (kilograms), height 
(meters), WC (centimeters), and hip circumference (centimeters) 
were measured in each subject by a single trained researcher (JPM) 
in the morning following an overnight fast. Height was measured to 
the nearest 0.01 m using a wall-mounted stadiometer (Seca). Body 
mass, weight, and fat mass/fat-free mass (FFM) were measured 
using a calibrated digital platform scale with bioelectrical impedance 
functionality (Tanita BC-418MA body composition analyzer). WC was 
measured at the midpoint between the distal border of the lowest rib 
and the superior border of the iliac crest (16). From these values, BMI 
(kilograms per meter squared), waist to hip ratio, and waist to height 
ratio were calculated.
MR imaging and MR spectroscopy. Adipose tissue (AT) content 
was measured by MR imaging (MRI) using a 1.5-T Philips Achieva 
scanner as previously described (17). Briefly, subjects lay in a prone 
position with arms extended above the head and they were scanned 
from their fingertips to their toes. Whole-body MRI was performed to 
measure total and regional AT volumes, recorded in liters. Abdominal 
subcutaneous AT (ASAT) and visceral AT (VAT) were defined as the 
subcutaneous and internal AT depots within the abdominal region (the 
region between the femoral heads) and at the top of the liver/bottom of 
the lungs. Total AT was calculated as the sum of total subcutaneous and 
internal AT volumes. MR spectroscopy (MRS) was obtained during the 
same scanning session to measure liver fat content (18).
Study population 2: UK Biobank
Subjects. Participant data from the UK Biobank imaging cohort 
were collected as previously described (19). Subjects included 
in this cohort were those scanned first between August 2014 and 
September 2016. MRI and patient meta-data were acquired through 
UK Biobank Access Application numbers 9914, 6569, and 23889. 
The UK Biobank has approval from the North West Multi-Centre 
Research Ethics Committee and it obtained written consent from all 
participants prior to involvement. The age range for inclusion was 44 
to 73 years, with individuals excluded if they had metal or electric 
implants or medical conditions that prohibited scanning, if they were 
pregnant, or if they planned surgery within 6 weeks.
Ethnicity classification. The ethnicity of UK Biobank participants 
was defined genetically through the projection of UK Biobank 
individuals into the principal component space of the 1000 Genomes 
Project samples and subsequent clustering based on a K-means approach, 
centering on the means of the first four principal components (20).
Anthropometric measurements. Anthropometric measurements 
were collected at UK Biobank assessment centers; height was measured 
using the Seca 202 height measure. The average of two blood pressure 
measurements, taken 2 minutes apart, was obtained using an automated 
device (Omron).
Blood biochemistry. Blood samples were collected from nonfasted 
UK Biobank participants and transported by commercial courier to a 
central laboratory where they were processed by standard biochemical 
techniques (21).
Imaging protocol. Images were acquired at the UK Biobank 
Imaging Centre at Cheadle (UK) using a Siemens 1.5-T MAGNETOM 
Aera scanner. VAT and ASAT were measured using the dual-echo Dixon 
Vibe protocol, providing a water- and fat-separated volumetric data set 
covering the neck to the knees, as previously described (22). Thigh 
volume and adiposity were obtained from image data as previously 
described (23). VAT and ASAT were defined as subcutaneous AT in the 
abdomen, measured from the top of the femoral head to the top of the 
thoracic vertebrae T9. A multi-echo spoiled-gradient-echo acquisition 
was used to calculate proton density fat fraction maps of the liver 
(24). Corrected T1 (cT1) values, as markers of liver inflammation and 
fibrosis, were measured in the UK Biobank as previously described 
(25).
Physical activity. Specific questions on the frequency and duration 
of walking (UK Biobank codes 864 and 874), moderate physical 
activity (884 and 894), and vigorous physical activity (904 and 914) 
match those used in the short form of the International Physical 
Activity Questionnaire (IPAQ) (26). This allowed the IPAQ measure 
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of total physical activity, metabolicequivalent minutes per week, to be 
calculated for UK Biobank participants. Individuals were excluded from 
IPAQ analysis if they selected “prefer not to answer” or “do not know” 
in response to any of the possible six questions on physical activity 
used to calculate the metabolicequivalent score. For any of the activity 
categories, a reading <10 minutes was recoded to 0, and values > 1,260 
per week (equivalent to an average of 3 h/d) were truncated at 1,260, as 
recommended (27).
Statistical analysis
Descriptive statistics were obtained for anthropometric and MR mea-
surements. Analyses were carried out in males and females separately, 
given the well-established sex differences in body fat distribution. The 
overall effect of ethnicity on study outcomes was assessed using linear 
regression adjusting for age and BMI for ethnic comparison of VAT, 
ASAT, percentage of VAT, and liver fat fraction. For UK Biobank analy-
ses, Deprivation Index and IPAQ scores were also included in the linear 
regression model. Liver fat and liver enzyme values were log-trans-
formed prior to analysis in order to address the nonnormally distributed 
nature of the data. We performed a sample size–weighted fixed-effects 
meta-analysis to combine data from both cohorts. Significance was de-
fined as P < 0.0002, following Bonferroni correction for multiple tests 
(250). All data were presented as mean ± SD. Statistical analyses were 
performed using SPSS Statistics (version 23.0; IBM Corp.). All sta-
tistical graphs were plotted using GraphPad Prism (version 7.00 for 
Windows).
Results
A total of 747 volunteers (456 male and 291 female) from the 
Hammersmith cohort were included, with an ethnic distribution of 
82% EUR, 12% SA, and 5.8% AC and a mean age of 42.6 ± 14.9 years 
(range, 17-75 years). Baseline characteristics by ethnic group and 
sex are shown in Table 1. Data from 9,533 UK Biobank individuals 
(4,592 males and 4,941 females) are presented in Table 2; the ethnic 
distribution was 98.2% EUR, 1.3% SA, and 0.5% AC, with a mean age 
of 55.5 ±  .5 years (range, 40-70 years).
In both the Hammersmith and UK Biobank cohorts, male SA 
were shorter and they weighed less compared with counterpart EUR 
(Tables 1-2). Female SA were shorter compared with female EUR and 
they presented with a lower body mass than female EUR and AC in 
both cohorts (Tables 1-2).
Sex- and ethnicity-specific distributions of AT and liver fat fraction are 
shown in Figure 1 (Hammersmith cohort) and Figure 2 (UK Biobank 
cohort). Female AC from the Hammersmith cohort had lower liver fat 
fraction compared with both counterpart EUR and counterpart SA (AC: 
1.2% ± 1.5%; EUR: 4.1% ± 11.1%; SA: 6.7% ± 12.3%; P < 0.0001 for 
both; Figure 1H). We did not detect any differences in VAT or liver fat 
between either male or female SA and EUR in either cohort. No ethnic 
differences in the liver inflammation marker cT1 were observed in UK 
Biobank data (Table 4). Male AC presented with lower VAT compared 
with male EUR in the UK Biobank (EUR: 4.4 ± 1.5 L; AC: 3.6 ± 1.7 L; 
P < 0.0001; Table 4, Figure 2).
Female AC presented with lower VAT compared with both counterpart 
EUR (P < 0.0001) and counterpart SA (P < 0.0001) in the Hammersmith 
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Table 3). In both the Hammersmith and UK Biobank cohorts, bioelec-
trical impedance data revealed lower FFM in male and female SA men 
compared with counterpart EUR and AC (P < 0.0001; Tables 3-4). In 
the Hammersmith cohort, SA of both sexes presented with a higher 
body fat percentage compared with respective populations of EUR 
(P < 0.0001; Table 3).
VAT as a percentage of body fat was lower in AC compared with EUR 
and SA in both the UK Biobank cohort (AC vs. EUR: men, P < 0.0001; 
women, P < 0.0001; AC vs. SA: men, P < 0.001; women, P < 0.0001) 
and the Hammersmith cohort (AC vs. EUR: women, P < 0.0001; AC vs. 
SA: women, P < 0.0001). The ratio of VAT to (VAT + ASAT) was higher 
in male EUR compared with SA in the UK Biobank cohort (P < 0.0001; 
Table 4). Female EUR presented with higher VAT/(VAT + ASAT) 
compared with SA in the UK Biobank cohort (P < 0.0001; Table 4) 
and presented with a higher ratio compared with AC in both cohorts 
(P < 0.0001 for both; Tables 3-4). Thigh volume was lower in male and 
female SA compared with counterpart EUR and AC in the UK Biobank 
cohort (P < 0.0001 for all; Table 4). No significant ethnic differences in 
thigh adiposity were observed in either sex. Blood chemistry data from 
the UK Biobank are shown in Table 5. Male AC presented with lower 
triglycerides compared with SA (male SA: 2.14 ± 1.26 mmol/L; male 
AC: 1.15 ± 0.49 mmol/L; P < 0.0001). No ethnic differences in glycated 
hemoglobin (HbA1c) or liver enzymes (alkaline phosphatase, alanine 
aminotransferase, and gamma-glutamyl transferase) were observed in 
either sex (Table 5).
Statistical assessment of ethnic differences after combining the data 
from both the Hammersmith and UK Biobank cohorts is shown in 
Table 6. No significant differences in VAT (men, P = 0.65; women, 
P = 0.44) or liver fat fraction (men, P = 0.11; women, P = 0.09) were 
observed between EUR and SA of either sex.
Discussion
In this cross-sectional study, we investigated ethnic variation in anthro-
pometry and body fat distribution in adult EUR, SA, and AC in two 
separate UK-based populations. There was a high degree of consensus 
between both cohorts regarding patterns of sex and ethnic differences, 
including a notable lack of difference between SA and EUR in VAT and 
liver fat, two depots previously proposed to underpin ethnic differences 
in developing features of metabolic syndrome.
Previous studies have shown that adult SA present with a higher body fat 
percentage, lower lean mass, and greater central visceral fat compared 
with adult EUR (4-7). This “thin-fat phenotype” reflects a body com-
position characterized by reduced muscle mass but increased adiposity, 
a pattern that appears to manifest in the neonatal period. Additional 
studies have indicated that VAT is associated with insulin resistance, 
increased inflammatory markers, and metabolic syndrome morbidities 
in populations of SA (28,29). This predisposition to increased cen-
tral obesity, reduced FFM, and elevated circulating triglycerides and 
cholesterol is thought to contribute to the increased susceptibility to 
developing metabolic syndrome–associated morbidities in SA (30-32). 
However, after adjustment for age and BMI, we found no differences in 
VAT between SA and EUR, in either sex, in either the Hammersmith or 
the UK Biobank cohorts. These data are in agreement with those of pre-
viously published studies, which also failed to show consistently higher 
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Ectopic accumulation of lipids in the liver is also a key marker of car-
diovascular risk (8). A limited number of studies have assessed ethnic 
differences in liver fat; the mediators of atherosclerosis in South Asians 
living in America and multi-ethnic study of atherosclerosis studies found 
a greater liver fat content in SA compared with all other ethnic groups 
(33); the molecular study of health assessment and risk in ethnic groups 
study found higher liver fat in SA compared with EUR (35). In contrast to 
these findings, we found no differences in liver fat or cT1 between SA and 
EUR of either sex, results that were consistent across both study cohorts. 
It should be noted that although results were in accord using two differ-
ent liver fat–assessment methods (MRS for the Hammersmith cohort and 
multi-echo MRI in the UK Biobank cohort), a large level of natural vari-
ation in the range of liver fat values was observed using both techniques, 
which may have contributed to the lack of observed statistical differences.
Figure 1  Sex- and ethnicity-specific distribution of adipose tissue (AT) and intrahepatocellular lipid in the 
Hammersmith cohort. (A,B) Total AT, (C,D) abdominal subcutaneous adipose tissue (ASAT), (E,F) visceral adipose 
tissue (VAT), and (G,H) log liver fat fraction (%) in men and women of white European (EUR), South Asian (SA), and 
Afro-Caribbean (AC) descent; n = 747. Data presented as box and whisker plots and as mean and SD in panels 
G and H; data analyzed by one-way ANCOVA with Bonferroni correction for pairwise comparisons adjusted for 
age and BMI; ***P < 0.001.
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In agreement with published reports (3,36), AC in our study were 
heavier, were taller, and presented with a significantly reduced percent-
age of body fat compared with SA and EUR. We also found male and 
female AC to have significantly less VAT and liver fat compared with 
other ethnicities, in both cohorts. This favorable adiposity profile has 
previously been reported in regard to VAT (37) and liver fat (38), and it 
is paradoxical, given the increased prevalence (almost double) of T2D 
and hypertension in AC compared with EUR for any given BMI (39). A 
high ratio of visceral to subcutaneous fat was previously associated with 
impaired adipogenesis and insulin resistance (40). Here, we found that 
EUR presented with higher VAT/(ASAT + VAT) values compared with 
SA and AC in both cohorts, an effect that would seem to be at odds with 
the increased susceptibility to metabolic disease observed in SA (7).
Increased muscle mass, as seen in AC, was associated with improved 
insulin sensitivity through increased glucose uptake and oxidization 
and it may play a role in manifesting a favorable metabolic profile (41). 
Indeed, the significant 5- to 6-kg reduction we observed in FFM (as a 
proxy for muscle mass) in SA of both sexes in both cohorts represents 
a potential mechanism for the adverse metabolic phenotype observed 
in SA, with lower muscle mass associated with reduced insulin sen-
sitivity and a higher risk of T2D (41). In addition, a reduction in FFM 
negatively affects various physiological processes and reflects a low-
ered resting energy expenditure, reductions in neuromuscular capacity, 
fatigue, and an increased risk of developing injury (42). These data are 
further reflected in the significant reduction of thigh volume in SA of 
both sexes compared with counterpart EUR and AC in the UK Biobank 
cohort, with no accompanying differences in thigh adiposity. However, 
it should be noted that the relationship between FFM and various mea-
sures of glucose metabolism is ambiguous, with more than half of the 
publications included in a 2016 meta-analysis reporting no relationship 
or an inverse relationship between FFM and markers of glucose homeo-
stasis (43).
Determining the clinical significance of the ethnic differences in body 
fat and FFM is complicated by the potentially altered function of these 
Figure 2 Sex- and ethnicity-specific distribution of adipose tissue and intrahepatocellular lipid in the UK 
Biobank. (A,B) Visceral adipose tissue (VAT), (C,D) abdominal subcutaneous adipose tissue (ASAT), 
and (E,F) log liver fat fraction in men and women of white European (EUR), South Asian (SA), and Afro-
Caribbean (AC) descent; n = 9,533. Data presented as box and whisker plots and as mean and standard 
deviation in panels E and F; data analyzed by one-way ANCOVA with Bonferroni correction for pairwise 
comparisons adjusted for age and BMI; ***P < 0.001.
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tissues across different ethnicities (44). Furthermore, as the lack of dif-
ferences we observed in VAT and ASAT between SA and EUR attests, 
it is, in effect, the reduction in FFM that is responsible for the increased 
body fat percentage in SA, as opposed to an actual increase in fat. The 
only way to definitively answer these questions will be to link anthro-
pometry and body composition to clinical outcomes and diagnoses in 
longitudinal analyses. Unfortunately, we are currently restricted by the 
limited amount of disease status and classification data available from 
the UK Biobank for the individuals included in this study. However, it 
is hoped that as more participants are scanned, including the collection 
of imaging data for the same individual at multiple time points, longitu-
dinal and outcome studies will become feasible.
The statistical approach we employed to assess ethnic differences in 
anthropometry and body composition is worth consideration. By adjust-
ing for BMI in our analysis, we attempted to remove its potential con-
founding influence on ethnic differences in body fat. However, within 
this statistical adjustment is the tacit acceptance that BMI behaves sim-
ilarly in different ethnicities. Accumulated evidence suggests that male 
and female SA have a greater risk for developing cardiovascular disease 
at lower BMI levels than other ethnicities (45). Ethnic differences may 
therefore exist in the strength of the relationships between body size 
and metabolic and cardiovascular risk factors, and this has prompted 
calls for lower BMI cutoffs for SA (46). However, directly excluding 
this confounder for our analyses by matching individuals on BMI is 
hindered by the lack of consensus regarding appropriate BMI cutoffs 
for SA, mostly due to variation within SA themselves (47). It should be 
noted that even without adjustment for BMI, we found no statistical dif-
ferences between SA and EUR regarding VAT or liver fat. Furthermore, 
combining the two data sets also revealed no significant differences 
between EUR and SA in VAT or liver fat fraction, in either sex.
The strengths of this study lie in the relatively large number of partic-
ipants and the experimental techniques used to measure body fat and 
liver fat deposition, which are considered the gold standard (17,24). 
The weaknesses lie in the lack of blood biochemistry data for the 
Hammersmith cohort and the lack of insulin levels for the UK Biobank 
cohort. In addition, UK Biobank participants were not fasted prior to 
sample collection, and data are therefore unsuitable to accurately char-
acterize ethnic differences in glucose metabolism and insulin sensitivity. 
The long-term evaluation of glucose control afforded by HbA1c analysis 
somewhat overcomes this lack of continuity we see in blood sample 
collection. However, we observed no significant ethnic differences in 
HbA1c, suggesting no ethnic differences in metabolic disease in the UK 
Biobank. Furthermore, the lack of metabolic data (e.g., fasted blood 
biochemistry samples) and insufficient information on disease classifi-
cation in the data sets restrict our ability to currently link fat depots to 
pathophysiology. In order to substantiate the role of VAT and liver fat, 
or lack thereof, we are therefore limited to indirectly characterizing our 
study groups as “normal” on the basis of our comprehensive replication 
of previously published ethnic differences in anthropometry (4-6).
With regard to additional outcomes, assessment of ectopic pancre-
atic fat was not available in either cohort and would have provided 
an opportunity to investigate a depot linked to the pathophysiol-
ogy of metabolic disease (48). Last, both cohorts may be subject to 
“healthy volunteer” selection bias (37). Neither the Hammersmith 
cohort nor the UK Biobank cohort is fully representative of the gen-
eral population. Furthermore, the ethnic differences in body com-
position, or lack thereof, we present here are limited to UK-based 
populations. There are striking differences in body fat and metabolic 
profiles between UK-based ethnic minorities and individuals living 
in their ancestral country of origin (49,50). This is an effect further 
TABLE 6 Ethnic comparison by sex
EUR − SA EUR − AC SA − AC
Difference (95% CI) P value Difference (95% CI) P value Difference (95% CI) P value
Male
Body fat (%) −3.1 (−4.3 to 2.9) <0.0001 0.60 (−1.7 to 2.9) 0.61 1.95 (−0.49 to 4.4) 0.12
Fat-free mass (kg) 6.47 (5.2 to 7.8) <0.0001 1.31 (−1.0 to 3.7) 0.27 −5.11 (−7.8 to −2.45) 0.0001
Liver-fat fraction (%) −0.09 (−0.24 to 0.07) 0.28 0.52 (0.23 to 0.80) 0.002 0.30 (−0.03 to 0.63) 0.08
VAT (L) 0.17 (−0.14 to 0.47) 0.29 1.80 (1.27 to 2.38) <0.0001 1.61 (0.99 to 2.24) <0.0001
ASAT (L) −0.65 (−0.96 to −0.34) <0.0001 0.54 (−0.01 to 1.09) 0.05 0.62 (−0.002 to 1.24) 0.05
VAT (%) −0.08 (−0.49 to 0.34) 0.72 2.0 (1.24 to 2.67) <0.0001 2.1 (1.23 to 2.88) <0.0001
VAT/(ASAT + VAT) 0.03 (0.003 to 0.05) 0.03 0.07 (0.04 to 0.09) <0.0001 0.05 (0.02 to 0.09) 0.01
Female
Body fat (%) −2.3 (−4.0 to −0.62) 0.01 −0.32 (2.2 to 1.6) 0.74 −2.3 (−4.8 to 0.23) 0.08
Fat-free mass (kg) 4.7 (3.4 to 6.0) <0.0001 −0.36 (−1.9 to 1.2) 0.66 −5.5 (−7.1 to −3.0) <0.0001
Liver-fat fraction (%) −0.19 (−0.41 to 0.02) 0.08 0.56 (0.30 to 0.80) <0.0001 −0.06 (−0.38 to 0.27) 0.73
VAT (L) 0.21 (−0.07 to 0.49) −0.14 1.58 (1.27 to 1.88) <0.0001 1.35 (0.93 to 1.78) <0.0001
ASAT (L) 0.01 (−0.49 to 0.51) 0.97 0.71 (0.14 to 1.28) 0.01 0.78 (0.02 to 1.53) 0.04
VAT (%) −0.06 (−0.41 to 0.28) 0.72 1.57 (1.20 to 1.95) <0.0001 1.67 (1.16 to 2.17) <0.0001
VAT/(ASAT + VAT) 0.01 (−0.01 to 0.03) 0.36 0.08 (0.06 to 0.11) <0.0001 0.07 (0.04 to 0.10) <0.0001
Sample size–weighted fixed-effects meta-analysis performed to combine data from both Hammersmith and UK Biobank cohorts to increase power. Data presented as mean 
difference (95% CI) meta-analyzed across two studies per trait and analyzed by one-way ANCOVA with Bonferroni pairwise correction, setting a threshold significance at P < 
0.0002, highlighted in bold.
AC, individuals of Afro-Caribbean descent; ASAT, abdominal subcutaneous adipose tissue; EUR, individuals of European descent; SA, individuals of South Asian descent; VAT, 
visceral adipose tissue.
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confounded by differences in body composition between SA living in 
rural and urban areas (51).
Overall, we demonstrate a high degree of continuity in ethnic and sex 
differences in anthropometry and body composition in two separate 
UK-based populations. The lack of difference in VAT and liver fat we 
observed between SA and EUR suggests that these adverse metabolic 
depots may not be responsible for the disproportionate increase in met-
abolic syndrome–associated morbidities in SA.O
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